Prevalence of Depression Among Patients With Alopecia Areata (AA_DEP)

Assessment of the Prevalence and Severity of Depression Among Patients With Alopecia Areata Attending Dermatology Clinics: A Cross-Sectional Study

This study aims to assess how common depression is among patients with alopecia areata at Sohag University Hospital using a questionnaire. It is an observational study with no treatment involved.

Study Overview

• Status: Not yet recruiting
• Conditions: Depression; Alopecia Areata Depression
• Intervention / Treatment: Other: Observation only

Detailed Description

This is a cross-sectional observational study designed to evaluate the prevalence of depression among patients with alopecia areata attending the dermatology outpatient clinic at Sohag University Hospital. Alopecia areata is an autoimmune condition characterized by non-scarring hair loss and may be associated with psychological distress.

The study will include patients diagnosed clinically with alopecia areata. Data will be collected through structured interviews and the use of a validated depression screening questionnaire. No therapeutic intervention will be applied during the study.

The aim of the study is to assess the psychological burden of alopecia areata and identify the frequency of depressive symptoms among affected patients. The findings may help in improving holistic patient care by addressing both dermatological and psychological aspects of the disease.

• Study Type: Observational
• Enrollment (Estimated): 100

Contacts and Locations

• Study Contact: Name: Omima Atef, MD; Phone Number: 01098970741; Email: omimaatef64@gmail.com

Study Locations

• Egypt
  • Sohag, Egypt
    • Sohag university hospital
    • Contact: Omima Atef, MD; Phone Number: 01098970741; Email: omimaatef64@gmail.com
    • Contact: Email: omimaatef64@gmail.com
    • Principal Investigator: Omima Atef, MD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Patients with clinically diagnosed alopecia areata attending the dermatology outpatient clinic at Sohag University Hospital. The study population includes adult patients aged 18 years and above who are willing to participate in the study.

Description

Inclusion Criteria:

• Patients diagnosed with alopecia areata Age 18 years and above Attending dermatology outpatient clinic at Sohag University Hospital Willing to participate and provide informed consent

Exclusion Criteria:

• Patients with other causes of hair loss Patients with known psychiatric disorders prior to alopecia areata diagnosis Patients refusing participation

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Alopecia areata patients; Patients diagnosed with alopecia areata attending the dermatology outpatient clinic at Sohag University Hospital. This is an observational cross-sectional study with no interventions. Data will be collected using a structured questionnaire to assess depressive symptoms.	Other: Observation only; This is an observational cross-sectional study with no therapeutic or experimental intervention. Data will be collected using a structured questionnaire to assess depression among patients with alopecia areata.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Prevalence of depression among patients with alopecia areata	The primary outcome is to assess the prevalence of depressive symptoms among patients with alopecia areata attending the dermatology outpatient clinic at Sohag University Hospital. Depression will be evaluated using a structured validated questionnaire.	At enrollment

Collaborators and Investigators

• Sponsor: Sohag University
• Investigators: Principal Investigator: Omima Atef, MD, ? Faculty of Medicine, Sohag University, Egypt; Principal Investigator: Omima Atef, ? Faculty of Medicine, Sohag University, Egypt

Study record dates

Study Major Dates

• Study Start (Estimated): September 1, 2027
• Primary Completion (Estimated): March 1, 2028
• Study Completion (Estimated): April 1, 2028

Study Registration Dates

• First Submitted: May 5, 2026
• First Submitted That Met QC Criteria: July 13, 2026
• First Posted (Actual): July 17, 2026

Study Record Updates

• Last Update Posted (Actual): July 17, 2026
• Last Update Submitted That Met QC Criteria: July 13, 2026
• Last Verified: July 1, 2026

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Behavioral Symptoms; Behavior; Depression
• Other Study ID Numbers: AA _ Dep_ Omima _ sohag _2026

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: Individual participant data (IPD) will not be shared due to patient confidentiality and ethical considerations. The data collected in this study will be used solely for the purposes of the current research analysis and will not be made publicly available. Aggregated results may be published in scientific journals.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No